163 related articles for article (PubMed ID: 28057806)
1. 12/15-Lipoxygenase Inhibition or Knockout Reduces Warfarin-Associated Hemorrhagic Transformation After Experimental Stroke.
Liu Y; Zheng Y; Karatas H; Wang X; Foerch C; Lo EH; van Leyen K
Stroke; 2017 Feb; 48(2):445-451. PubMed ID: 28057806
[TBL] [Abstract][Full Text] [Related]
2. Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke.
Cheng G; Zhao W; Xin Y; Huang G; Liu Y; Li Z; Zhan M; Li Y; Lu L; van Leyen K; Liu Y
J Neurochem; 2021 May; 157(3):586-598. PubMed ID: 33481248
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of hemorrhagic transformation in ischemic stroke occurring during warfarin anticoagulation: an experimental study in mice.
Pfeilschifter W; Spitzer D; Czech-Zechmeister B; Steinmetz H; Foerch C
Stroke; 2011 Apr; 42(4):1116-21. PubMed ID: 21330626
[TBL] [Abstract][Full Text] [Related]
4. Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia.
Jin G; Arai K; Murata Y; Wang S; Stins MF; Lo EH; van Leyen K
Stroke; 2008 Sep; 39(9):2538-43. PubMed ID: 18635843
[TBL] [Abstract][Full Text] [Related]
5. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
Pfeilschifter W; Bohmann F; Baumgarten P; Mittelbronn M; Pfeilschifter J; Lindhoff-Last E; Steinmetz H; Foerch C
Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol ameliorates warfarin-induced hemorrhagic transformation after cerebral ischemia in mice.
Kitashoji A; Egashira Y; Mishiro K; Suzuki Y; Ito H; Tsuruma K; Shimazawa M; Hara H
Stroke; 2013 Oct; 44(10):2862-8. PubMed ID: 23881959
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting 12/15-lipoxygenase to treat acute stroke in permanent and tPA induced thrombolysis models.
Karatas H; Eun Jung J; Lo EH; van Leyen K
Brain Res; 2018 Jan; 1678():123-128. PubMed ID: 29079502
[TBL] [Abstract][Full Text] [Related]
8. Impact of 12/15-Lipoxygenase on Brain Injury After Subarachnoid Hemorrhage.
Gaberel T; Gakuba C; Zheng Y; Lépine M; Lo EH; van Leyen K
Stroke; 2019 Feb; 50(2):520-523. PubMed ID: 30602353
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke.
Yigitkanli K; Pekcec A; Karatas H; Pallast S; Mandeville E; Joshi N; Smirnova N; Gazaryan I; Ratan RR; Witztum JL; Montaner J; Holman TR; Lo EH; van Leyen K
Ann Neurol; 2013 Jan; 73(1):129-35. PubMed ID: 23192915
[TBL] [Abstract][Full Text] [Related]
10. Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.
Vergouwen MD; Casaubon LK; Swartz RH; Fang J; Stamplecoski M; Kapral MK; Silver FL;
Stroke; 2011 Apr; 42(4):1041-5. PubMed ID: 21350204
[TBL] [Abstract][Full Text] [Related]
11. Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: therapeutic potential of PCC.
Pfeilschifter W; Spitzer D; Pfeilschifter J; Steinmetz H; Foerch C
PLoS One; 2011; 6(10):e26087. PubMed ID: 22039437
[TBL] [Abstract][Full Text] [Related]
12. Following experimental stroke, the recovering brain is vulnerable to lipoxygenase-dependent semaphorin signaling.
Pekcec A; Yigitkanli K; Jung JE; Pallast S; Xing C; Antipenko A; Minchenko M; Nikolov DB; Holman TR; Lo EH; van Leyen K
FASEB J; 2013 Feb; 27(2):437-45. PubMed ID: 23070608
[TBL] [Abstract][Full Text] [Related]
13. Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.
Rai G; Joshi N; Jung JE; Liu Y; Schultz L; Yasgar A; Perry S; Diaz G; Zhang Q; Kenyon V; Jadhav A; Simeonov A; Lo EH; van Leyen K; Maloney DJ; Holman TR
J Med Chem; 2014 May; 57(10):4035-48. PubMed ID: 24684213
[TBL] [Abstract][Full Text] [Related]
14. Experimental model of warfarin-associated intracerebral hemorrhage.
Foerch C; Arai K; Jin G; Park KP; Pallast S; van Leyen K; Lo EH
Stroke; 2008 Dec; 39(12):3397-404. PubMed ID: 18772448
[TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke.
Ploen R; Sun L; Zhou W; Heitmeier S; Zorn M; Jenetzky E; Veltkamp R
J Cereb Blood Flow Metab; 2014 Mar; 34(3):495-501. PubMed ID: 24346690
[TBL] [Abstract][Full Text] [Related]
16. Increased 12/15-Lipoxygenase Leads to Widespread Brain Injury Following Global Cerebral Ischemia.
Yigitkanli K; Zheng Y; Pekcec A; Lo EH; van Leyen K
Transl Stroke Res; 2017 Apr; 8(2):194-202. PubMed ID: 27838820
[TBL] [Abstract][Full Text] [Related]
17. SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice.
Ito A; Niizuma K; Shimizu H; Fujimura M; Hasumi K; Tominaga T
Brain Res; 2014 Aug; 1578():38-48. PubMed ID: 25016287
[TBL] [Abstract][Full Text] [Related]
18. The potential of 12/15-lipoxygenase inhibitors in stroke therapy.
van Leyen K; Holman TR; Maloney DJ
Future Med Chem; 2014; 6(17):1853-5. PubMed ID: 25495979
[No Abstract] [Full Text] [Related]
19. Baicalein and 12/15-lipoxygenase in the ischemic brain.
van Leyen K; Kim HY; Lee SR; Jin G; Arai K; Lo EH
Stroke; 2006 Dec; 37(12):3014-8. PubMed ID: 17053180
[TBL] [Abstract][Full Text] [Related]
20. Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats.
Copin JC; Merlani P; Sugawara T; Chan PH; Gasche Y
Exp Neurol; 2008 Sep; 213(1):196-201. PubMed ID: 18590727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
